Effect of Preventive Analgesia with Nalbuphine and Dexmedetomidine in Endoscopic Sinus Surgery
Table 2
Hemodynamic values.
Measurement time
Group N
Group DN
Group C
HR values
T1
72.84 ± 1.48
72.59 ± 1.48
73.34 ± 1.48
T2
85.41 ± 0.80a
74.78 ± 0.80ab
93.47 ± 0.80
T3
84.53 ± 0.69a
74.84 ± 0.69ab
91.63 ± 0.69
T4
82.69 ± 0.79a
75.22 ± 0.79ab
91.16 ± 0.79
T5
77.66 ± 1.01a
71.56 ± 1.01ab
81.28 ± 1.01
MAP values
T1
92.38 ± 1.01
93.22 ± 1.01
91.75 ± 1.01
T2
102.56 ± 0.84a
94.66 ± 0.84ab
111.28 ± 0.84
T3
103.47 ± 0.89a
94.75 ± 0.89ab
111.97 ± 0.89
T4
102.78 ± 0.91a
94.81 ± 0.91ab
116.34 ± 0.91
T5
97.72 ± 1.02a
94.19 ± 1.02ab
102.75 ± 1.02
Values are presented as mean ± SD. HR, heart rate; MAP, mean arterial pressure; group N, preoperative nalbuphine injection; group DN, preoperative nalbuphine combined with dexmedetomidine injection; group C, preoperative saline injection. compared with T1 in the same group; a compared with group C; b compared with group N.